These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 8851268

  • 1. [The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty].
    Heinz M, Theiss W, van de Flierdt E, Söhngen M.
    Vasa; 1996; 25(1):65-72. PubMed ID: 8851268
    [Abstract] [Full Text] [Related]

  • 2. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Schwartz L, Bourassa MG, Lespérance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR.
    N Engl J Med; 1988 Jun 30; 318(26):1714-9. PubMed ID: 2967433
    [Abstract] [Full Text] [Related]

  • 3. The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.
    Horrocks M, Horrocks EH, Murphy P, Lane IF, Ruttley MS, Fligelstone LJ, Watson HR.
    Int Angiol; 1997 Jun 30; 16(2):101-6. PubMed ID: 9257670
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty.
    Mueller MR, Salat A, Stangl P, Murabito M, Pulaki S, Boehm D, Koppensteiner R, Ergun E, Mittlboeck M, Schreiner W, Losert U, Wolner E.
    Thromb Haemost; 1997 Sep 30; 78(3):1003-7. PubMed ID: 9308744
    [Abstract] [Full Text] [Related]

  • 9. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G, Seipp U.
    Arzneimittelforschung; 1990 Aug 30; 40(8):932-8. PubMed ID: 2242087
    [Abstract] [Full Text] [Related]

  • 10. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H, Kopp H, Mulfinger A, Spielberger M, Todt M, Schuster CJ, Meyer J.
    Prog Clin Biol Res; 1989 Aug 30; 301():417-21. PubMed ID: 2508112
    [No Abstract] [Full Text] [Related]

  • 11. Acetylsalicylic acid--reocclusion--prophylaxis after angioplasty (ARPA-study). A randomized double-blind trial of two different dosages of ASA in patients with peripheral occlusive arterial disease.
    Weichert W, Meents H, Abt K, Lieb H, Hach W, Krzywanek HJ, Breddin HK.
    Vasa; 1994 Aug 30; 23(1):57-65. PubMed ID: 8154176
    [Abstract] [Full Text] [Related]

  • 12. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Aug 30; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 13. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy.
    Minar E, Ehringer H, Ahmadi R, Dudczak R, Porenta G.
    Thromb Haemost; 1987 Aug 04; 58(2):718-23. PubMed ID: 2960029
    [Abstract] [Full Text] [Related]

  • 14. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
    van der Loo B, Kovacevic T, Krieger E, Banyai S, Banyai M, Amann-Vesti BR, Jagacic D, Rousson V, Koppensteiner R.
    Clin Hemorheol Microcirc; 2005 Aug 04; 32(2):159-68. PubMed ID: 15764824
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dose-dependent side effects of acetylsalicylic acid therapy. Results of a prospective randomized clinical study in patients with peripheral arterial occlusive disease].
    Ranke C, Creutzig A, Luska G, Wagner HH, Galanski M, Bode-Böger S, Frölich J, Avenarius HJ, Hecker H, Alexander K.
    Med Klin (Munich); 1993 Oct 15; 88(10):571-6. PubMed ID: 8272018
    [Abstract] [Full Text] [Related]

  • 17. On-treatment function testing of platelets and long-term outcome of patients with peripheral arterial disease undergoing transluminal angioplasty.
    van der Loo B, Braun J, Koppensteiner R.
    Eur J Vasc Endovasc Surg; 2011 Dec 15; 42(6):809-16. PubMed ID: 21917489
    [Abstract] [Full Text] [Related]

  • 18. Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty.
    Do DD, Mahler F.
    Radiology; 1994 Nov 15; 193(2):567-71. PubMed ID: 7972781
    [Abstract] [Full Text] [Related]

  • 19. [Outpatient PTA in the treatment of arterial occlusive diseases].
    Rieser R, Rückner R.
    Rofo; 1995 Apr 15; 162(4):330-4. PubMed ID: 7749089
    [Abstract] [Full Text] [Related]

  • 20. [Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities].
    Minar E, Ahmadi RA, Ehringer H, Marosi L, Czembirek H, Konecny U.
    Wien Klin Wochenschr; 1986 Jan 24; 98(2):33-40. PubMed ID: 2938339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.